UVB Light Modulates Human Intestinal Microbiome (Bosman et al. 2019) - Synopsis

UVB Light Modulates Human Intestinal Microbiome (Bosman et al., 2019) — Literature Synopsis

Citation & Metadata

• Title: Skin Exposure to Narrow Band Ultraviolet (UVB) Light Modulates the Human Intestinal Microbiome
• Authors: Else S. Bosman, Arianne Y. Albert, Harvey Lui, Jan P. Dutz, and Bruce A. Vallance (University of British Columbia & BC Children’s Hospital Research Institute, Vancouver, BC, Canada)
• Journal: Frontiers in Microbiology, October 24, 2019 · Volume 10, Article 2410
• DOI: 10.3389/fmicb.2019.02410 (DOI · SciDB) · PMID: 31695684 (PubMed · Europe PMC) · PMCID: PMC6821880 (PMC Full Text · Direct Frontiers PDF)
• ClinicalTrials.gov: NCT03962673 · NCBI SRA: PRJNA539987

---

1. Silo Routing & Cross-Links Across the Biohacking Vault

This clinical pilot study bridges three core silos in the Biohacking knowledge graph by demonstrating for the first time in humans that cutaneous narrow-band UVB (NB-UVB, $311\text{ nm}$) phototherapy directly remodels the intestinal microbiome via a novel skin–gut axis:

Vault Silo	Connected Topic Notes	Mechanistic & Protocol Relevance
04 - Longevity & Environment (Primary)	UV Exposure, Nitric Oxide & Photobiology · Photobiomodulation (Red & NIR Light Therapy) · Sourcing - Photobiomodulation, UV & Full-Spectrum Light Panels	Establishes quantitative dosing parameters for sub-erythemal $311\text{ nm}$ NB-UVB phototherapy ($70\%$ MED starting dose, $+20\%$ progression across 3 exposures/week) and proves seasonal/high-latitude UV deprivation directly drives gut dysbiosis.
03 - Diagnostics & Quantified Self (Secondary)	Microbiome Diversity & Keystone Species · GI-MAP, Shotgun Metagenomics & SIBO · SCFA Production (Butyrate) & Postbiotics · Intestinal Permeability (Zonulin, L-Glutamine)	Demonstrates rapid (within 1 week) restoration of Shannon ($\alpha$) and Weighted UniFrac ($\beta$) diversity in vitamin D-insufficient subjects, specifically enriching butyrate/SCFA-producing Lachnospiraceae (Lachnospira, Fusicatenibacter, Agathobacter, Dorea), Ruminococcus, and Rikenellaceae (Alistipes).
02 - Compounds & Molecules (Secondary)	Vitamin D3, K2 & Calcium Homeostasis · Sourcing - Essential Micronutrients, Minerals & Fatty Acids	Compares oral winter Vitamin ${\text{D}}_3$ supplementation ($\text{VDS+}$, average $1,389\text{ IU/day}$, maintaining serum $25\text{(OH)D}>75\text{ nmol/L}$ and preserving baseline microbial diversity) against non-supplemented winter insufficiency ($\text{VDS-}$, $25\text{–}75\text{ nmol/L}$), and quantifies cutaneous $7\text{-dehydrocholesterol}$ negative feedback ($r=-0.566$).

---

2. Executive Synopsis & Core Hypothesis

• Background: Chronic immune-mediated inflammatory diseases such as inflammatory bowel disease (IBD) and multiple sclerosis (MS) exhibit a strong latitude gradient and seasonal relapse pattern correlated with low ambient UVB exposure, low serum 25-hydroxyvitamin D ($25\text{(OH)D}$), and intestinal dysbiosis. While Vitamin D receptor (VDR) signaling is known to regulate intestinal tight junction proteins, autophagy ($ATG16L1$), and antimicrobial peptides, it remained unknown whether skin exposure to UVB light directly alters the human gut microbiota, and whether this effect depends on baseline vitamin D status.
• Core Finding: Three full-body sub-erythemal exposures to Narrow Band UVB ($311\text{ nm}$) within a single week increased serum $25\text{(OH)D}$ across the cohort by an average of $+7.3\text{ nmol/L}$ ($+10.1\%,p=0.002$) and significantly increased both alpha diversity (Shannon and Chao1 richness/evenness) and beta diversity in participants who had not been taking oral vitamin D supplements ($\text{VDS-}$ group), elevating their gut microbiome diversity to match the already-diverse oral vitamin D-supplemented ($\text{VDS+}$) group.

---

3. Study Design, Cohort & Methods

Cohort & Stratification

• Location & Season: Vancouver, BC, Canada ($49^{\circ }\text{N}$ latitude) between February and April 2018, when ambient solar UVB irradiance was zero/negligible.
• Participants: $n=21$ healthy Caucasian females Completing the study (out of 23 enrolled; 2 excluded for sample collection non-compliance), ages $19\text{–}40$ (mean age $28.43\pm 0.85\text{ years}$), restricted to Fitzpatrick Skin Types I–III with no sunny travel or tanning bed use in the prior 3 months and stable habitual diet.
• Vitamin D Supplementation Stratification:
  • $\text{VDS-}$ Group ($n=12,57.1\%$): Took no oral vitamin D supplements during the 3 winter months prior to the study. Mean age $27.0\pm 0.93\text{ years}$ (6 Skin Type II, 6 Skin Type III). Majority started in the vitamin D insufficient range ($25\text{–}75\text{ nmol/L}$) (except one outlier at $116\text{ nmol/L}$).
  • $\text{VDS+}$ Group ($n=9,42.9\%$): Took oral vitamin D supplements ($500\text{–}3,500\text{ IU/day}$, mean $1,389\text{ IU/day}$, with 6 of 9 taking $1,000\text{ IU/day}$) over the prior 3 winter months. Mean age $30.33\pm 1.36\text{ years}$ (1 Skin Type I, 2 Skin Type II, 6 Skin Type III). Most started in the vitamin D sufficient range ($>75\text{ nmol/L}$) ($p=0.0006$ vs. $\text{VDS-}$).

NB-UVB Phototherapy Protocol

• Hardware: Houva II high-output phototherapy cabinet equipped with 48 Philips TL01 NB-UVB bulbs (peak emission at $311\text{ nm}$), calibrated each morning for irradiance stability.
• Schedule: 3 full-body exposures within a single week (wearing only underwear and UV-blocking goggles).
• Dosimetry (Starting at $70\%$ Minimal Erythemal Dose, MED):
  • Fitzpatrick Type I: $105{\text{ mJ/cm}}^2$ starting dose
  • Fitzpatrick Type II: $140{\text{ mJ/cm}}^2$ starting dose
  • Fitzpatrick Type III: $168{\text{ mJ/cm}}^2$ starting dose
  • Progression: Dose increased by $+20\%$ at visits 2 and 3 unless mild erythema/itchiness occurred (2 Type III subjects held dose steady on visit 3 due to mild erythema after visit 2).

Bioassays & Sequencing Pipeline

• Serum $25\text{(OH)D}$: Peripheral venous blood drawn up to 2 days pre-UVB and $\ge 24\text{ hours}$ after the 3rd UVB exposure; combined $25{\text{(OH)D}}_2+25{\text{(OH)D}}_3$ quantified via LC-MS/MS (LifeLabs).
• Fecal 16S rRNA Microbiome Profiling:
  • 4 stool samples per subject using OMNIGene® GUT DNA-stabilizing kits: Timepoints 1 & 2 collected in the 3 days pre-UVB; Timepoints 3 & 4 collected in the 3 days post-UVB.
  • DNA extracted via MO BIO PowerFecal DNA Kit; 16S rRNA V6–V8 hypervariable regions amplified with Phusion polymerase and sequenced on Illumina MiSeq (Integrated Microbiome Resource, Dalhousie University).
  • Bioinformatics: Microbiome Helper pipeline (Cutadapt, VSEARCH, QIIME2, Deblur singleton filtering, SILVA taxonomy database, Phyloseq v1.24.2, ALDEx2 centered log-ratio [clr] transformation, Weighted UniFrac PERMANOVA, and LEfSe Linear Discriminant Analysis).

---

4. Key Quantitative Findings & Mechanisms

4.1 Cutaneous Serum $25\text{(OH)D}$ Response & Negative Feedback Regulation

• Overall Cohort Increase: Serum $25\text{(OH)D}$ rose significantly by $+7.3\pm 2.06\text{ nmol/L}$ ($p=0.002$), representing an average $+10.1\%$ increase within 1 week of three NB-UVB sessions.
• Subgroup Response & Baseline Ceiling Effect:
  • $\text{VDS-}$ Group: $+10.1\pm 2.6\text{ nmol/L}$ mean increase.
  • $\text{VDS+}$ Group: $+3.8\pm 3.1\text{ nmol/L}$ mean increase.
  • Inverse Correlation with Starting $25\text{(OH)D}$: Serum $25\text{(OH)D}$ gain was strongly negatively correlated with baseline serum $25\text{(OH)D}$ concentration (Spearman $r=-0.566,p=0.008$; Pearson $r=-0.566,p=0.0075$). This confirms homeostatic negative feedback in keratinocytes, where sufficient circulating vitamin D suppresses $7\text{-dehydrocholesterol}$ availability/reductase dynamics to prevent vitamin D toxicity from sun exposure.
  • Fitzpatrick Skin Type Equivalence: Adjusted MED dosing produced equivalent $25\text{(OH)D}$ responses between Skin Types II and III ($p=0.207$).

4.2 Gut Microbiome Alpha & Beta Diversity Shifts

• Baseline Deficit in Unsupplemented Winter Cohort ($\text{VDS-}$): Prior to UVB exposure, $\text{VDS-}$ participants exhibited significantly lower microbial richness and evenness than $\text{VDS+}$ participants:
  • Shannon Index (Pre-UVB $\text{VDS-}$ vs. $\text{VDS+}$): $p_{\text{adj}}=0.0019$
  • Chao1 Richness (Pre-UVB $\text{VDS-}$ vs. $\text{VDS+}$): $p_{\text{adj}}=0.017$
• Rapid Alpha Diversity Restoration by NB-UVB:
  • Linear mixed-effects modeling across the 4 timepoints showed a highly significant increase in the Shannon index over time in the $\text{VDS-}$ group ($p=0.0001$), whereas the already-sufficient $\text{VDS+}$ group remained stable.
  • Pooled pre- vs. post-UVB comparison confirmed a significant Shannon diversity increase in $\text{VDS-}$ ($p=0.0162$ / multiple-comparison ANOVA $p_{\text{adj}}=0.024$), normalizing $\text{VDS-}$ alpha diversity to match the $\text{VDS+}$ cohort post-UVB.
• Beta Diversity (PERMANOVA on Weighted UniFrac / clr Data):
  • Whole-cohort intra-individual UVB effect: $p=0.04$.
  • $\text{VDS-}$ Group Pre- vs. Post-UVB: Highly significant community structure shift (PERMANOVA $p=0.001$, Tukey’s HSD $p=0.041$).
  • $\text{VDS+}$ Group Pre- vs. Post-UVB: No significant shift (PERMANOVA $p=0.723$).

4.3 Phylum-Level & Genus-Level Taxonomic Remodeling (LEfSe)

In the $\text{VDS-}$ group, paired phylum-level analysis after NB-UVB exposure demonstrated:

• Firmicutes: Significant increase ($p=0.0287$)
• Bacteroidetes: Significant decrease ($p=0.0164$)
• Proteobacteria: Significant increase ($p=0.0493$)
• Verrucomicrobia: No statistically significant group-level change, though 4 participants displayed a marked post-UVB surge.

Table: Differentially Enriched Taxa Post-UVB in the $\text{VDS-}$ Group (LEfSe Analysis)

Phylum	Family	Genus / Taxon	LDA Score (${\log }_{10}$)	Adjusted $p$-value (Benjamini-Hochberg)	Functional / Clinical Association
Firmicutes	Lachnospiraceae	Family overall	4.140	$0.038$	Core butyrate/SCFA producers; depleted in IBD & MS; positively correlated with serum $25\text{(OH)D}$ ($p=0.0025$).
Firmicutes	Lachnospiraceae	Lachnospira	3.308	$0.040$	Directly correlated with serum $25\text{(OH)D}$ concentration ($p=0.0383$).
Firmicutes	Lachnospiraceae	Agathobacter	2.924	$0.031$	Butyrate producer; enriched by UVB independently of serum $25\text{(OH)D}$ ($p=0.662$).
Firmicutes	Lachnospiraceae	Dorea	2.916	$0.031$	Commensal SCFA-associated Lachnospiraceae genus.
Firmicutes	Lachnospiraceae	CAG-56	2.892	$0.031$	Commensal Lachnospiraceae clade.
Firmicutes	Lachnospiraceae	Fusicatenibacter	2.654	$0.041$	Strongly correlated with serum $25\text{(OH)D}$ concentration ($p=0.000055$).
Bacteroidetes	Rikenellaceae	Alistipes	3.914 (Family: 4.010)	$0.031$	Associated with healthy microbiota meta-analyses & SCFA/tryptophan metabolism.
Proteobacteria	Desulfovibrionaceae	Bilophila	2.872 (Family: 3.579)	$0.031$	Bile-acid/taurine-metabolizing commensal clade.
Firmicutes	Clostridiales vadinBB60	Clostridiales	2.739 (Family: 3.501)	$0.040$	Commensal Clostridiales group.
Firmicutes	Clostridia Family XIII	Family XIII AD3011	2.565 (Family: 3.501)	$0.031$	Commensal Clostridia clade.
Actinobacteria	Coriobacteriaceae	Collinsella	2.752 (Family: 3.299)	$0.039$	Bile acid and sterol-modifying actinobacterium.
Bacteroidetes	Marinifilaceae	Odoribacter	2.774 (Family: 2.992)	$0.031$	Succinate- and SCFA-producing commensal.
Firmicutes	Ruminococcaceae	Intestinimonas	3.089	$0.041$	Butyrate producer (capable of converting lysine and fructoselysine to butyrate).
Firmicutes	Ruminococcaceae	Ruminococcus	2.841	$0.031$	Keystone resistant-starch degrader and SCFA cross-feeder.

4.4 Dual Mechanism of the Skin–Gut Axis

1. Endocrine Vitamin D–VDR Pathway ($25\text{(OH)D}$-Dependent):
   • Cutaneous $311\text{ nm}$ UVB converts $7\text{-dehydrocholesterol}$ $\to$ pre-vitamin ${\text{D}}_3$ $\to$ hepatic $25\text{(OH)D}$.
   • Circulating vitamin D activates intestinal epithelial and immune Vitamin D Receptors (VDR), upregulating tight junction proteins, $ATG16L1$-mediated autophagy, and antimicrobial peptides, selectively fostering Lachnospiraceae (Lachnospira, $p=0.0383$; Fusicatenibacter, $p=0.000055$).
2. Direct Photo-Immunological Trafficking ($25\text{(OH)D}$-Independent):
   • Local UVB exposure modulates cutaneous innate and adaptive immune cells (e.g., expansion of ${\text{CD4}}^{+}{\text{CD25}}^{+}{\text{Foxp3}}^{+}$ regulatory T cells and suppression of Th17/IFN pathways), which traffic systemically to the gut lamina propria to release mediators that reshape commensal niches (explaining why genera like Agathobacter increase post-UVB independently of serum $25\text{(OH)D}$ levels, $p=0.662$).

---

5. Actionable Biohacking Takeaways & Protocol Integration

1. Winter Vitamin ${\text{D}}_3$ Sufficiency Preserves Baseline Microbiome Alpha Diversity:
   • In high-latitude winters ($>40^{\circ }\text{N/S}$), failing to supplement oral Vitamin ${\text{D}}_3$ causes serum $25\text{(OH)D}$ to drop below $75\text{ nmol/L}$ ($30\text{ ng/mL}$), which directly precipitates a measurable loss of gut microbial alpha diversity (Shannon and Chao1). Maintaining serum $25\text{(OH)D}>75\text{–}100\text{ nmol/L}$ ($30\text{–}40+\text{ ng/mL}$) via oral Vitamin D3 + K2 prevents this winter diversity collapse.
2. Targeted NB-UVB Phototherapy as a Microbiome & Butyrate Intervention:
   • Sub-erythemal $311\text{ nm}$ Narrow Band UVB (3 exposures/week at $70\%$ MED: $105\text{–}168{\text{ mJ/cm}}^2$ depending on Fitzpatrick phototype) rapidly enriches keystone butyrate-producing Lachnospiraceae (Lachnospira, Fusicatenibacter, Agathobacter) and Ruminococcaceae (Ruminococcus, Intestinimonas) within 7 days—even without dietary changes.
3. Synergy Between Oral ${\text{D}}_3$ and Phototherapy:
   • Because certain Lachnospiraceae members (Agathobacter) respond to NB-UVB independently of serum $25\text{(OH)D}$ concentration ($p=0.662$), oral Vitamin ${\text{D}}_3$ supplementation does not fully replace the photo-immunological benefits of controlled solar exposure.
4. Confounding Variable in Microbiome Testing:
   • When tracking longitudinal 16S or Shotgun Metagenomic stool tests, control for recent sun travel, season, and UVB lamp exposure, as just 3 UVB sessions in 7 days can significantly shift Firmicutes/Bacteroidetes ratios and Shannon diversity in vitamin D-insufficient states.

---

6. Direct Online Full-Text & PDF Access

• PubMed Central (Open-Access HTML & PDF): PMCID: PMC6821880 (PMC Full Text)
• Frontiers in Microbiology Direct PDF: Download / View Original PDF
• PubMed & DOI: PMID: 31695684 (PubMed · Europe PMC) | DOI: 10.3389/fmicb.2019.02410 (DOI · SciDB)